Scotts Miracle-Gro vs CVR Partners, LP
SMG and UAN side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How SMG and UAN compare
Scotts Miracle-Gro is the larger company, worth 3.4 times as much as CVR Partners, LP ($3.6B against $1.1B).
On earnings, CVR Partners, LP is cheaper: it trades at 6.8× trailing earnings, against 51.7× for Scotts Miracle-Gro.
CVR Partners, LP grew revenue faster over the last twelve months (17.5% versus 4.6% for Scotts Miracle-Gro).
CVR Partners, LP keeps more of each dollar of sales as profit, with a net margin of 23.7% compared with 2.1% at Scotts Miracle-Gro.
Both pay dividends: Scotts Miracle-Gro yields 4.2% and CVR Partners, LP 10.2%.
CVR Partners, LP scores higher on the StockData Score (15 against 12 for Scotts Miracle-Gro), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | SMG | UAN |
|---|---|---|
| Size and price | ||
| Market cap | $3.6B | $1.1B |
| Share price | $62.55 | $102.67 |
| Change, 1 year | 10.3% | 3.5% |
| Change, 5 years | −61.3% | 30.1% |
| Beta (5Y) | −0.03 | −0.57 |
| Employees | 5,200 | 320 |
| StockData Score | ||
| Total score | 12 | 15 (better) |
| Valuation score | 2 | 6 (better) |
| Growth score | 3 (better) | 2 |
| Performance score | 3 (better) | 2 |
| Health score | 1 | 2 (better) |
| Dividend score | 3 | 3 |
| Valuation | ||
| P/E | 51.7× | 6.8× (better) |
| P/S | 1.0× (better) | 1.6× |
| EV/EBITDA | 15.0× | 5.5× (better) |
| P/FCF | 13.8× | 7.5× (better) |
| FCF yield | 7.2% | 13.3% (better) |
| Fair value | $55.40 | $234.25 |
| Margin of safety | −12.9% | 56.2% (better) |
| Growth | ||
| Revenue growth (TTM) | 4.6% | 17.5% (better) |
| Revenue growth, 5Y average | −3.7% | 11.6% (better) |
| Net income growth (TTM) | – | 82.2% |
| EPS growth (TTM) | – | 82.2% |
| EPS growth, 5Y average | −18.4% | – |
| Profitability | ||
| Gross margin | 31.8% | 33.5% (better) |
| Operating margin | 11.0% | 28.1% (better) |
| Net margin | 2.1% | 23.7% (better) |
| FCF margin | 7.6% | 21.4% (better) |
| Return on invested capital | 12.3% | – |
| Financial health | ||
| Net debt / EBITDA | 5.45 | 1.57 (better) |
| Interest coverage | 3.4× | – |
| Current ratio | 1.21 | 3.01 (better) |
| Altman Z-score | 2.41 | – |
| Piotroski F-score | 7 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | 4.2% | 10.2% (better) |
| Payout ratio | 209% | – |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | −18.5% | – |
| Buyback yield | 0.33% | – |
| Shareholder yield | 4.6% | 10.2% (better) |
| Ownership | ||
| Held by institutions | 86.5% | 53.6% |
| Held by insiders | 53.4% | 78.2% |
| Insider net buying, 12 months | −$5.6M | – |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 19.0% | 8.6% |
Go deeper
- SMG stock overview
- SMG income statement
- SMG valuation and score
- UAN stock overview
- UAN income statement
- UAN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.